Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior.

Fry RB, Ray MN, Cobaugh DJ, Weissman NW, Kiefe CI, Shewchuk RM, Saag KG, Curtis JR, Allison JJ.

Arthritis Rheum. 2007 Dec 15;57(8):1539-45.

2.

Improving the risk-benefit ratio of NSAID therapy in the elderly.

Hodinka L.

Scand J Rheumatol Suppl. 1991;91:3-8. Review.

PMID:
1771394
3.

GI risk and risk factors of NSAIDs.

Laine L.

J Cardiovasc Pharmacol. 2006;47 Suppl 1:S60-6. Review.

PMID:
16785831
4.

The problems of using NSAIDs in the elderly.

Hughes GR.

Scand J Rheumatol Suppl. 1991;91:19-25. Review.

PMID:
1771392
5.

A review of NSAID complications: gastrointestinal and more.

Beehrle DM, Evans D.

Lippincotts Prim Care Pract. 1999 May-Jun;3(3):305-15. Review.

PMID:
10711132
6.

Nonsteroidal anti-inflammatory drug toxicity: increased risk in the elderly.

Weinblatt ME.

Scand J Rheumatol Suppl. 1991;91:9-17. Review.

PMID:
1771396
7.

Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.

Ofman JJ, Maclean CH, Straus WL, Morton SC, Berger ML, Roth EA, Shekelle PG.

Arthritis Rheum. 2003 Aug 15;49(4):508-18. Review.

8.

The problems and pitfalls of NSAID therapy in the elderly (Part I).

Johnson AG, Day RO.

Drugs Aging. 1991 Mar;1(2):130-43. Review.

PMID:
1794009
9.

Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature.

Gibson GR, Whitacre EB, Ricotti CA.

Arch Intern Med. 1992 Mar;152(3):625-32. Review.

PMID:
1546927
10.

Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illness.

Targownik LE, Thomson PA.

Can Fam Physician. 2006 Sep;52(9):1100-5. Review.

11.

Implications of NSAID therapy in elderly patients.

Buchanan WW.

J Rheumatol Suppl. 1990 Feb;20:29-32. Review.

PMID:
2182854
12.

Prevalence of NSAID-induced gastrointestinal morbidity and mortality.

Haslock I.

J Rheumatol Suppl. 1990 Feb;20:2-6. Review.

PMID:
2182852
13.

Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?

Kiltz U, Zochling J, Schmidt WE, Braun J.

Rheumatology (Oxford). 2008 Sep;47(9):1342-7. doi: 10.1093/rheumatology/ken123. Epub 2008 May 13. Review.

PMID:
18477642
14.
15.

Non-steroidal antiinflammatory drugs. A review.

Winzeler S, Rosenstein BD.

AAOHN J. 1998 May;46(5):253-9; quiz 260-1. Review.

PMID:
9652239
17.

The safety of drugs for OTC use: what evidence is required for an NSAID switch?

MacDonald TM, Beard K, Bruppacher R, Hasford J, Lewis M, Logan RF, McNaughton D, Tubert-Bitter P, Van Ganse E, Moore N.

Pharmacoepidemiol Drug Saf. 2002 Oct-Nov;11(7):577-84. Review.

PMID:
12462134
18.

Non-steroidal anti-inflammatory drugs--uses and complications.

Ng SC.

Singapore Med J. 1992 Oct;33(5):510-3. Review.

PMID:
1455279
19.

Minimizing the risk of NSAID-induced GI bleeding.

Hirschowitz BI.

Cleve Clin J Med. 1999 Oct;66(9):524-7. Review.

PMID:
10535177
20.

Therapeutic choices for rheumatic disorders.

Hughes G.

Gerontology. 1988;34 Suppl 1:27-32. Review.

PMID:
2977119

Supplemental Content

Support Center